Quick Takeaways
- Point72 Asset Management, L.P. filed SCHEDULE 13G for Tonix Pharmaceuticals Holding Corp. Common Stock, par value $0.001 per share (TNXP).
- Disclosed ownership: 9.2%.
- Date of event: 29 Dec 2025.
Point72 Asset Management, L.P. - 29 Dec 2025 SCHEDULE 13G Report for Tonix Pharmaceuticals Holding Corp. Common Stock, par value $0.001 per share (TNXP)
- Filing Manager
- Point72 Asset Management, L.P.
- Reporting Manager
- Point72 Asset Management, L.P.
- Symbol
- TNXP
- Shares outstanding
- 13,424,543 shares
- Disclosed Ownership
- 1,235,058 shares
- Ownership
- 9.2%
- Form type
- SCHEDULE 13G
- Filing time
- 31 Dec 2025, 16:10:20 UTC
- Date of event
- 29 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Point72 Asset Management, L.P. disclosed 9.2% ownership in Tonix Pharmaceuticals Holding Corp. Common Stock, par value $0.001 per share (TNXP) on 29 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 31 Dec 2025, 16:10.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 9.2% | 1,235,058 | 0 | 1,235,058 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 9.2% | 1,235,058 | 0 | 1,235,058 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 9.2% | 1,235,058 | 0 | 1,235,058 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |